These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus. Puig M; Mihalik K; Tilton JC; Williams O; Merchlinsky M; Connors M; Feinstone SM; Major ME Hepatology; 2006 Sep; 44(3):736-45. PubMed ID: 16941702 [TBL] [Abstract][Full Text] [Related]
4. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus. Torresi J; Johnson D; Wedemeyer H J Hepatol; 2011 Jun; 54(6):1273-85. PubMed ID: 21236312 [TBL] [Abstract][Full Text] [Related]
5. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection. Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959 [TBL] [Abstract][Full Text] [Related]
6. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection. Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982 [TBL] [Abstract][Full Text] [Related]
7. Success and failure of virus-specific T cell responses in hepatitis C virus infection. Neumann-Haefelin C; Thimme R Dig Dis; 2011; 29(4):416-22. PubMed ID: 21894013 [TBL] [Abstract][Full Text] [Related]
8. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Urbani S; Amadei B; Fisicaro P; Tola D; Orlandini A; Sacchelli L; Mori C; Missale G; Ferrari C Hepatology; 2006 Jul; 44(1):126-39. PubMed ID: 16799989 [TBL] [Abstract][Full Text] [Related]
9. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen. Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection. van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746 [TBL] [Abstract][Full Text] [Related]
11. Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee. Woollard DJ; Grakoui A; Shoukry NH; Murthy KK; Campbell KJ; Walker CM Hepatology; 2003 Nov; 38(5):1297-306. PubMed ID: 14578870 [TBL] [Abstract][Full Text] [Related]
13. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain. Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961 [TBL] [Abstract][Full Text] [Related]
14. Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus. Schnuriger A; Dominguez S; Guiguet M; Harfouch S; Samri A; Ouazene Z; Slama L; Simon A; Valantin MA; Thibault V; Autran B; AIDS; 2009 Oct; 23(16):2079-89. PubMed ID: 19710595 [TBL] [Abstract][Full Text] [Related]
15. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice. Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486 [TBL] [Abstract][Full Text] [Related]
16. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection. Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108 [TBL] [Abstract][Full Text] [Related]
17. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40. Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104 [TBL] [Abstract][Full Text] [Related]
18. HCV persistence and immune evasion in the absence of memory T cell help. Grakoui A; Shoukry NH; Woollard DJ; Han JH; Hanson HL; Ghrayeb J; Murthy KK; Rice CM; Walker CM Science; 2003 Oct; 302(5645):659-62. PubMed ID: 14576438 [TBL] [Abstract][Full Text] [Related]
19. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development. Lamonaca V; Missale G; Urbani S; Pilli M; Boni C; Mori C; Sette A; Massari M; Southwood S; Bertoni R; Valli A; Fiaccadori F; Ferrari C Hepatology; 1999 Oct; 30(4):1088-98. PubMed ID: 10498664 [TBL] [Abstract][Full Text] [Related]
20. Relation between viral fitness and immune escape within the hepatitis C virus protease. Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]